Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
African American
31%
Anastrozole
27%
Axilla
27%
Axillary Staging
27%
Axillary Ultrasound
22%
Benign Breast Disease
27%
Biomarkers of Response
27%
Breast Biopsy
27%
Breast Cancer
100%
Breast Cancer Family History
27%
Breast Cancer Patients
34%
Breast Cancer Treatment
27%
Breast Oncology
27%
Breast Reconstruction
58%
Calcium-dependent
27%
Caregivers
27%
Colorectal Cancer Screening
27%
Consensus Guidelines
27%
Dermal Flap
27%
Ductal Carcinoma in Situ
55%
Dyadic Analysis
27%
Endocrine Resistance
27%
Estrogen Receptor-positive
27%
Excision
27%
Fecal Occult Blood Test
27%
Health Outcomes
27%
HER2-negative Breast Cancer
27%
Implant-based Reconstruction
27%
Inferior Dermal Flap
27%
Informal Caregivers
27%
Ki-67
27%
Mastectomy
20%
Modern Techniques
27%
Multimodality
27%
Neoadjuvant
27%
Nuclear Import
27%
Overall Survival
27%
Palbociclib
27%
Partial Breast Irradiation
27%
Phase II Trial
27%
Psychosocial Outcomes
27%
Rate of Return
20%
Re-excision
27%
Re-excision Rate
23%
Recurrence Rate
20%
Retrospective Review
32%
Sigma Phase
27%
Sonographic Analysis
27%
Triple-negative Breast Cancer
27%
Ultrasound-guided Core Needle Biopsy
22%
Medicine and Dentistry
Accelerated Partial Breast Irradiation
27%
Acellular Dermal Matrix
6%
Arm
27%
Axilla
27%
Benign Tumor
27%
Brachytherapy
10%
Breast Biopsy
27%
Breast Cancer
86%
Breast Ptosis
6%
Breast Reconstruction
33%
Breast Tumor
6%
Cancer Susceptibility
27%
Cancer Therapy
27%
Colorectal Cancer Screening
27%
Community-Based Intervention
5%
Cosmesis
6%
External Beam Radiotherapy
10%
Family History of Breast Cancer
27%
Health Care
9%
Health Care Cost
33%
Health Care Personnel
5%
Implant
13%
Intraductal Carcinoma
55%
Isotopes of Calcium
27%
Long-Term Outcome
27%
Mastectomy
24%
Needle Biopsy
27%
Nuclear Export
27%
Occult Blood Test
22%
Oncology
34%
Quadrantectomy
31%
Radiology
6%
Randomized Controlled Trial
8%
Recurrence Risk
6%
Recurrent Disease
10%
S Phase
27%
Sentinel Lymph Node Biopsy
13%
Skin Flap
27%
Surgeon
9%
Survival Rate
10%
Systematic Review
27%
Tumor Recurrence
6%